Radiomics in Action

February 22, 2022 | Coverage

Rose HigginsBy Rose Higgins

The intersection of academic research and clinical trials.

Many academic researchers and life sciences organizations are leveraging radiomics, which is the science of advanced imaging analytics, to generate new clinical insights that may lead to widespread improvements in patient care.

For oncology therapeutics, in particular, radiomics is useful to academic researchers and trial sponsors to help identify which types of patients should be included in trials, as well as which patients are the most likely to benefit from those trials. Further, from a trial enrichment perspective, radiomics enables trial sponsors and researchers to ensure they obtain the most value out of trial efforts that leverage medical imaging and imaging endpoints.